Sex-Associated Biomarker Differences in CKD Progression and Mortality
Clinical Journal of the American Society of Nephrology · 2026-05 · 21 (5) · 765-774
DOI: 10.2215/cjn.0000000979 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 05.02.2026. Verfasst von Thomas McDonnell und 10 weiteren Autor:innen. Beteiligte Einrichtung: Donal O'Donoghue Renal Research Centre, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Kidney research UK.
Abstract (Originalsprache)
Key Points A higher risk of kidney failure and mortality persisted in men with CKD, despite adjusting for sociodemographic, clinical, and treatment factors. Differences in biomarkers linked to CKD progression and cardiovascular stress were observed between men and women after adjusting for eGFR and urine albumin-to-creatinine ratio. When adjusting for the differences in the biomarkers, the excess risk of kidney failure and mortality seen in men was eliminated.
Background
Men with CKD experience worse outcomes than women, a difference not fully explained by comorbidities or sociocultural factors. We explored whether sex-based differences in biomarkers could account for this difference in risk.
Methods
Our study included 1680 male and 1204 female participants with non–dialysis-dependent CKD and 84 controls from National Unified Renal Translational Research Enterprise-CKD, a prospective multicenter cohort study. Twenty-one biomarkers relating to kidney injury and fibrosis, inflammation, and cardiovascular stress were measured. Outcomes were kidney failure (eGFR
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Donal O'Donoghue Renal Research Centre, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom.
- Division of Cardiovascular Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, United Kingdom.
- Faculty of Health and Medical Sciences, School of Health Sciences, University of Surrey, Guildford, United Kingdom.
- Division of Laboratory Medicine, Diagnostic Department, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
- Leeds Institute of Medical Research, St James's University Hospital, School of Medicine, Leeds, United Kingdom.
- Department of Renal Medicine, Queen Elizabeth Hospital, University Hospitals of Birmingham, Birmingham, United Kingdom.
ORCID-Profile: Thomas McDonnell, Anthony Onoja, Rosamonde E Banks, Simon D S Fraser, Moin A Saleem, David C Wheeler, Nophar Geifman, Philip A Kalra
Förderung
- Kidney research UK
Zitieren
APA
McDonnell, T., Onoja, A., Vuilleumier, N., Banks, R. E., Cockwell, P., Fraser, S. D. S., Saleem, M. A., Wheeler, D. C., Geifman, N., Kalra, P. A., & Taal, M. W. (2026). Sex-Associated Biomarker Differences in CKD Progression and Mortality. Clinical Journal of the American Society of Nephrology, 21(5), 765-774. https://doi.org/10.2215/cjn.0000000979
Vancouver
McDonnell T, Onoja A, Vuilleumier N, Banks RE, Cockwell P, Fraser SDS, et al. Sex-Associated Biomarker Differences in CKD Progression and Mortality. Clinical Journal of the American Society of Nephrology. 2026;21(5):765-774. doi:10.2215/cjn.0000000979
BibTeX
@article{McDonnell2026,
author = {McDonnell, Thomas and Onoja, Anthony and Vuilleumier, Nicolas and Banks, Rosamonde E and Cockwell, Paul and Fraser, Simon D S and Saleem, Moin A and Wheeler, David C and Geifman, Nophar and Kalra, Philip A and Taal, Maarten W},
title = {Sex-Associated Biomarker Differences in CKD Progression and Mortality},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2026},
volume = {21},
number = {5},
pages = {765--774},
doi = {10.2215/cjn.0000000979}
}
EUVIMED